Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer

Podocalyxin overexpression associates with poor survival in pancreatic cancer (PDAC). We investigated whether podocalyxin expression correlates with treatment response or survival in neoadjuvant-treated PDAC. Through immunohistochemistry, we evaluated podocalyxin expression in 88 neoadjuvant and 143...

Descripción completa

Detalles Bibliográficos
Autores principales: Eurola, Annika, Ristimäki, Ari, Mustonen, Harri, Nurmi, Anna-Maria, Hagström, Jaana, Haglund, Caj, Seppänen, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110523/
https://www.ncbi.nlm.nih.gov/pubmed/33972616
http://dx.doi.org/10.1038/s41598-021-89134-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110523/
https://www.ncbi.nlm.nih.gov/pubmed/33972616
http://dx.doi.org/10.1038/s41598-021-89134-2

Ejemplares similares